Location: 599 Lexington Ave. – 32d Floor – Seminar Room, New York, NY
The Age of “Big Data” in Bioscience is Here, but are we prepared for it?
The bioscience research community is producing more and larger sets of data in its quest to understand biology and manage disease. Much of these data are being generated by teams of scientists spanning many institutions and geographies. As we come to appreciate these data as a new asset class, we need to understand how to properly manage, protect and share this asset so its value can be realized.
A distinguished panel of experts, including Louis C. Cullman, Esq., Partner, Intellectual Property, K&L Gates, LLP, Dr. Wanmei Ou, Healthcare Product Strategist, Oracle Health Sciences, Oracle and David Greenwald, PhD, Co-Founder and Managing Director, Relay Technology Management, will discuss managing and protecting “Big data” as i) intellectual property, ii) trade secrets and iii) open source. We will explore opportunities and challenges including storage and access issues, data protection, ownership (who owns the “$1,000 genome” data – the producer or the purchaser?) and future advances in analysis and utility.
For more details, visit MIT Enterprise Forum of New York.